Third Party Funds Group - Sub project (01.01.2024 – 01.01.2027)
Part of SFB 1607: Neue immunmodulierende und anti(lymph)angiogene Therapien für altersassoziierte, zur Erblindung führende Augenerkrankungen
Third Party Funds Group - Sub project (01.01.2024 – 01.01.2027)
Part of SFB 1607: Neue immunmodulierende und anti(lymph)angiogene Therapien für altersassoziierte, zur Erblindung führende Augenerkrankungen
Third party funded individual grant (01.08.2024 – 01.01.2027)
Third party funded individual grant (01.01.2023 – 01.01.2027)
Internally funded project (01.01.2024 – 01.01.2027)
Third party funded individual grant (01.01.2024 – 01.01.2027)
Third party funded individual grant (01.07.2026 – 31.12.2026)
Third party funded individual grant (01.01.2026 – 31.12.2026)
Third party funded individual grant (01.06.2026 – 31.12.2026)
Third party funded individual grant (01.01.2026 – 31.12.2026)